Driven Brands Receives Nasdaq Delisting Notice, Discloses Material Weaknesses & Delayed Financials

summarizeSummary

Driven Brands received a Nasdaq non-compliance notice due to its delayed 2025 Form 10-K, which stems from ongoing material weaknesses in internal controls and financial restatement issues, while also providing preliminary Q4 2025 and Q1 2026 results.

check_boxKey Events

• Nasdaq Non-Compliance Notice

  Driven Brands received a notice from Nasdaq for failing to timely file its 2025 Form 10-K, indicating non-compliance with listing rules. The company has until June 15, 2026, to submit a compliance plan.

• Delayed Financial Filings

  The company confirmed it will not meet the previously expected April 26, 2026 deadline for its 2025 Form 10-K and does not expect to timely file its Q1 2026 Form 10-Q.

• Material Weaknesses in Controls

  The delay and restatement efforts are attributed to ongoing internal review and identified material weaknesses in internal control over financial reporting and disclosure controls.

• Preliminary Financial Results

  The company provided preliminary unaudited results for Q4 2025, FY 2025, and Q1 2026, including revenue of $1.85-$1.86 billion for FY 2025, and Adjusted EBITDA expected to be lower than the prior year due to restatement expenses.

auto_awesomeAnalysis

This 8-K filing confirms significant operational and financial reporting challenges for Driven Brands. The receipt of a Nasdaq non-compliance notice, while not an immediate delisting, signals serious issues with the company's ability to meet its reporting obligations. This non-compliance is directly linked to previously disclosed material errors in financial statements requiring restatement and ongoing material weaknesses in internal control over financial reporting. The company's inability to provide a firm filing date for its 2025 Form 10-K and its expectation of a delayed Q1 2026 Form 10-Q further underscore the complexity and severity of these issues. While preliminary financial results for Q4 2025 and Q1 2026 were provided, the negative impact on Adjusted EBITDA due to restatement expenses highlights the financial cost of these problems. Investors should monitor the company's progress in remediating its material weaknesses and its ability to submit a compliance plan to Nasdaq by the June 15, 2026 deadline to avoid further listing complications.